Naftopidil
From Wikipedia, the free encyclopedia
| Systematic (IUPAC) name | |
|---|---|
| 1-[4-(2-methoxyphenyl)piperazin-1-yl]-3-(1-naphthyloxy)propan-2-ol | |
| Clinical data | |
| AHFS/Drugs.com | International Drug Names |
| Pregnancy cat. | ? |
| Legal status | ℞ Prescription only |
| Routes | Oral |
| Identifiers | |
| CAS number | 57149-07-2 |
| ATC code | None |
| PubChem | CID 4418 |
| UNII | R9PHW59SFN |
| Chemical data | |
| Formula | C24H28N2O3 |
| Mol. mass | 392.49 g/mol |
| SMILES | eMolecules & PubChem |
| |
Naftopidil (INN, marketed under the brand name Flivas) is an antihypertensive drug which acts as a selective α1-adrenergic receptor antagonist or alpha blocker.
[edit] See also
[edit] References
| This article does not cite any references or sources. Please help improve this article by adding citations to reliable sources. Unsourced material may be challenged and removed. (March 2010) |
|
| This antihypertensive-related article is a stub. You can help Wikipedia by expanding it. |

